Drug Shortage Report for ACT MEMANTINE
Report ID | 212001 |
Drug Identification Number | 02324067 |
Brand name | ACT MEMANTINE |
Common or Proper name | MEMANTINE 10MG FC TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | MEMANTINE HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 ud |
ATC code | N06DX |
ATC description | ANTI-DEMENTIA DRUGS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-11-29 |
Estimated end date | 2024-01-31 |
Actual end date | 2023-12-06 |
Shortage status | Resolved |
Updated date | 2023-12-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-12-07 | French | Compare |
v3 | 2023-12-07 | English | Compare |
v2 | 2023-11-30 | French | Compare |
v1 | 2023-11-30 | English | Compare |
Showing 1 to 4 of 4